Downstream Processing Featured Articles

1. Flu Shot During Pregnancy Shows Unexpected Benefits In Large Study 5/22/2012

   Getting a flu shot during pregnancy provides unanticipated benefits to the baby, according to the authors of a large population-based study examining the issue.

2. Lonza And Sartorius Stedim Biotech Enter Collaboration, Supply And Distribution Agreement In The Field Of Cell Culture Media 12/19/2012

   Lonza recently announced together with Sartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier, a long-term global collaboration, supply and distribution agreement in the field of cell culture media.

3. GE Healthcare launches modular biopharmaceutical factory, KUBio 9/4/2012

   GE Healthcare, the healthcare business of GE, today introduced KUBio™, an innovative off-the-shelf, modular factory designed to save manufacturers of biopharmaceuticals both time and money.  KUBio’s pre-made modules, which are assembled at a customer’s chosen site to make a fully functional ready-to-run bioprocessing facility, are significantly faster to install than constructing a traditional factory.

4. Pathobiology Professor's Vaccine Platform Gives Immune Systems A Boost 11/28/2012

   Dr. Bernhard Kaltenboeck, professor of pathobiology in Auburn University’s College of Veterinary Medicine, and research associates Erfan Chowdhury and Yihang Li have developed a vaccine platform to treat intracellular diseases for which antibodies are ineffective.

5. ATMI Acquires European Biotech Firm To Expand Portfolio Of Bioprocess Manufacturing And Single-Use Technology Products For The Life Sciences Industry 11/4/2010
   ATMI, Inc. (Nasdaq:ATMI), announced today it has acquired the Belgian biotechnology firm Artelis S.A., an innovator in the area of highly-efficient bioprocesses and technologies for cell culture research and manufacturing scale-up. The acquisition complements ATMI's leadership in ultrapure single-use films, bioreactors, and mixing systems for characterizing, developing, and manufacturing biopharmaceuticals and extends its global capabilities to a broad range of biopharmaceutical process expertise.
6. Ultrasound Idea: Prototype NIST/CU Bioreactor Evaluates Engineered Tissue While Creating It 5/2/2012

   Researchers at the National Institute of Standards and Technology (NIST) have developed a prototype bioreactor—a device for culturing cells to create engineered tissues—that both stimulates and evaluates tissue as it grows, mimicking natural processes while eliminating the need to stop periodically to cut up samples for analysis.

7. Injection-Free Vaccination 2/5/2013

   Injection-free vaccination technique could address global vaccine challenge for diseases such as HIV and malaria

8. FlexFill Single-Use Transfer Assembly 10/3/2011
   Meissner introduces its new FlexFill single-use biocontainer transfer assembly. The assembly is ideally suited for applications requiring fast and dependable aseptic transfer of small liquid process volumes.
9. Boehringer Ingelheim Implements Flexible Fully Disposable Up- And Downstream Manufacturing For Biopharmaceuticals 9/10/2012

   Boehringer Ingelheim has developed and now implemented a flexible set-up and operational approach for disposable technologies within its global biopharmaceutical development and manufacturing network.

10. Stellar Biotechnologies Announces Filing A US Letters Patent Application 10/4/2012

    Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) is very pleased to announce the filing of a US Letters Patent Application directed to protecting certain proprietary KLH manufacturing controls, KLH formulations and kits used in immunotoxicology and immune status testing which were invented by Drs. Chow, Sundsmo and Sagermann.